Venture Life Group PLC
LSE:VLG

Watchlist Manager
Venture Life Group PLC Logo
Venture Life Group PLC
LSE:VLG
Watchlist
Price: 39 GBX -0.64% Market Closed
Market Cap: 49.6m GBX
Have any thoughts about
Venture Life Group PLC?
Write Note

Venture Life Group PLC
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Venture Life Group PLC
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Venture Life Group PLC
LSE:VLG
Cash & Cash Equivalents
ÂŁ5.6m
CAGR 3-Years
-11%
CAGR 5-Years
-13%
CAGR 10-Years
27%
Unilever PLC
LSE:ULVR
Cash & Cash Equivalents
€1.3B
CAGR 3-Years
-32%
CAGR 5-Years
-20%
CAGR 10-Years
-9%
PZ Cussons PLC
LSE:PZC
Cash & Cash Equivalents
ÂŁ49.4m
CAGR 3-Years
-15%
CAGR 5-Years
0%
CAGR 10-Years
-3%
Science in Sport PLC
LSE:SIS
Cash & Cash Equivalents
ÂŁ1.5m
CAGR 3-Years
-43%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Warpaint London PLC
LSE:W7L
Cash & Cash Equivalents
ÂŁ5.5m
CAGR 3-Years
-6%
CAGR 5-Years
9%
CAGR 10-Years
N/A
HALEON PLC
LSE:HLN
Cash & Cash Equivalents
ÂŁ1B
CAGR 3-Years
55%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Venture Life Group PLC
Glance View

Market Cap
49.4m GBX
Industry
Consumer products

Venture Life Group Plc engages in the development, manufacture, and commercializing of products for the aging population. The company is headquartered in Bracknell, Berkshire and currently employs 119 full-time employees. The company went IPO on 2014-03-28. The firm is focused on developing, manufacturing and commercializing products for the global self-care market. The firm's segments include Brands, which includes sales of healthcare and skin care products under distribution agreements and direct to United Kingdom retailers, and Development and Manufacturing. Through its two Development and Manufacturing operations in Italy and Sweden, the Company also provides development and manufacturing services to companies in the medical devices and cosmetic sectors. Its product portfolio includes the UltraDEX and Dentyl oral care product ranges, the Balance Active range in the area of women's intimate healthcare, the Lift and Glucogel product ranges for hypoglycaemia, Gelclair and Pomi-T for oncology support, products for fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.

VLG Intrinsic Value
68.12 GBX
Undervaluation 43%
Intrinsic Value
Price

See Also

What is Venture Life Group PLC's Cash & Cash Equivalents?
Cash & Cash Equivalents
5.6m GBP

Based on the financial report for Jun 30, 2024, Venture Life Group PLC's Cash & Cash Equivalents amounts to 5.6m GBP.

What is Venture Life Group PLC's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
27%

Over the last year, the Cash & Cash Equivalents growth was 52%. The average annual Cash & Cash Equivalents growth rates for Venture Life Group PLC have been -11% over the past three years , -13% over the past five years , and 27% over the past ten years .

Back to Top